Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.

Asquith CRM, Laitinen T, Bennett JM, Godoi PH, East MP, Tizzard GJ, Graves LM, Johnson GL, Dornsife RE, Wells CI, Elkins JM, Willson TM, Zuercher WJ.

ChemMedChem. 2018 Jan 8;13(1):48-66. doi: 10.1002/cmdc.201700663. Epub 2017 Nov 27.

2.

Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34(+) cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers.

Preti RA, Chan WS, Kurtzberg J, Dornsife RE, Wallace PK, Furlage R, Lin A, Omana-Zapata I, Bonig H, Tonn T.

Cytotherapy. 2014 Nov;16(11):1558-1574. doi: 10.1016/j.jcyt.2014.03.006. Epub 2014 Jun 11.

3.

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models.

Dev IK, Dornsife RE, Hopper TM, Onori JA, Miller CG, Harrington LE, Dold KM, Mullin RJ, Johnson JH, Crosby RM, Truesdale AT, Epperly AH, Hinkle KW, Cheung M, Stafford JA, Luttrell DK, Kumar R.

Br J Cancer. 2004 Oct 4;91(7):1391-8.

4.

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA 3rd, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach JC, Townsend LB, Koszalka GW.

Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72.

5.

Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).

Chan JH, Chamberlain SD, Biron KK, Davis MG, Harvey RJ, Selleseth DW, Dornsife RE, Dark EH, Frick LW, Townsend LB, Drach JC, Koszalka GW.

Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):101-23. Erratum in: Nucleosides Nucleotides Nucleic Acids. 2002;21(1):109.

PMID:
10772705
6.

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.

Daluge SM, Good SS, Faletto MB, Miller WH, St Clair MH, Boone LR, Tisdale M, Parry NR, Reardon JE, Dornsife RE, Averett DR, Krenitsky TA.

Antimicrob Agents Chemother. 1997 May;41(5):1082-93.

8.

The anti-human immunodeficiency virus agent 3'-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells.

Sundseth R, Joyner SS, Moore JT, Dornsife RE, Dev IK.

Antimicrob Agents Chemother. 1996 Feb;40(2):331-5.

9.

Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.

Nair V, St Clair MH, Reardon JE, Krasny HC, Hazen RJ, Paff MT, Boone LR, Tisdale M, Najera I, Dornsife RE, et al.

Antimicrob Agents Chemother. 1995 Sep;39(9):1993-9.

10.

An enantiospecific synthesis of the human cytomegalovirus antiviral agent [(R)-3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic acid.

Chamberlain SD, Biron KK, Dornsife RE, Averett DR, Beauchamp L, Koszalka GW.

J Med Chem. 1994 Apr 29;37(9):1371-7.

PMID:
8176714
11.

Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.

Van Draanen NA, Tisdale M, Parry NR, Jansen R, Dornsife RE, Tuttle JV, Averett DR, Koszalka GW.

Antimicrob Agents Chemother. 1994 Apr;38(4):868-71.

12.

In vitro infection of human bone marrow by feline leukemia viruses.

Morgan RA, Dornsife RE, Anderson WF, Hoover EA.

Virology. 1993 Mar;193(1):439-42.

PMID:
8382406
13.

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.

Furman PA, Davis M, Liotta DC, Paff M, Frick LW, Nelson DJ, Dornsife RE, Wurster JA, Wilson LJ, Fyfe JA, et al.

Antimicrob Agents Chemother. 1992 Dec;36(12):2686-92.

14.

Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.

Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.

Exp Hematol. 1991 Sep;19(8):759-67.

PMID:
1714401
15.
16.

Pathogenic mechanisms of immunodeficiency syndrome and aplastic anemia induced by feline leukemia viruses.

Hoover EA, Quackenbush SL, Poss ML, Dornsife RE, Overbaugh JM, Donahue PR, Riedel NO, Vigilanti GA, Khiroya R, Mullins JI.

Dev Biol Stand. 1990;72:163-6. No abstract available.

PMID:
2178112
17.

In vitro erythrocytopathic activity of an aplastic anemia-inducing feline retrovirus.

Dornsife RE, Gasper PW, Mullins JI, Hoover EA.

Exp Hematol. 1989 Feb;17(2):138-44.

PMID:
2536328
18.

Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus.

Dornsife RE, Gasper PW, Mullins JI, Hoover EA.

Leuk Res. 1989;13(9):745-55.

PMID:
2552228
19.

Pathogenic and host range determinants of the feline aplastic anemia retrovirus.

Riedel N, Hoover EA, Dornsife RE, Mullins JI.

Proc Natl Acad Sci U S A. 1988 Apr;85(8):2758-62.

20.

Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.

Gasper PW, Thrall MA, Wenger DA, Macy DW, Ham L, Dornsife RE, McBiles K, Quackenbush SL, Kesel ML, Gillette EL, et al.

Nature. 1984 Nov 29-Dec 5;312(5993):467-9.

PMID:
6438532

Supplemental Content

Loading ...
Support Center